Pune-based Serum Institute of India (SII), the manufacturer of the Covishield vaccine has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday. "The Serum Institute of India (SII) put up an application to the Drugs Controller General of India (DCGI) on Wednesday seeking permission to manufacture the COVID-19 vaccine, Sputnik V, in India," a source said. Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories. If the Drug Controller General of India grants permission then the Serum Institute of India (SII) will become the seventh company to manufacture Russia's Sputnik V vaccine. A consignment of 30 lakh doses of Sputnik V landed in Hyderabad on Tuesday.

Source: dna June 03, 2021 09:56 UTC